Literature DB >> 32915472

Lupus anticoagulant in patients with COVID-19.

Ariella Tvito1, Eli Ben-Chetrit2, Frederic Shmuel Zimmerman3, Elad Asher4, Yigal Helviz3.   

Abstract

Entities:  

Keywords:  COVID-19; anticoagulation; antiphospholipid antibodies; lupus anticoagulant; thromboembolic events

Year:  2020        PMID： 32915472     DOI： 10.1111/ijlh.13334

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  6 in total

1.  Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review.

Authors:  Muhanad Taha; Lobelia Samavati
Journal:  RMD Open       Date:  2021-05

2.  The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.

Authors:  Lucia Novelli; Francesca Motta; Maria De Santis; Aftab A Ansari; M Eric Gershwin; Carlo Selmi
Journal:  J Autoimmun       Date:  2020-12-14       Impact factor: 7.094

Review 3.  COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.

Authors:  Ruth Fernandez-Ruiz; Jacqueline L Paredes; Timothy B Niewold
Journal:  Transl Res       Date:  2020-12-19       Impact factor: 7.012

4.  Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.

Authors:  Kuo-Tung Tang; Bo-Chueh Hsu; Der-Yuan Chen
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

5.  Assessment of COVID -19 associated coagulopathy and multiple hemostatic markers: a single center study in Egypt.

Authors:  Azza Abdelaal; Ahmed Abu-Elfatth; Lamees M Bakkar; Hanan G Abd El-Azeem; Helal F Hetta; Eman R Badawy
Journal:  Infection       Date:  2022-09-22       Impact factor: 7.455

6.  Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

Authors:  Thomas Foret; Virginie Dufrost; Lucie Salomon Du Mont; Patricia Costa; Benjamin Lefevre; Patrick Lacolley; Veronique Regnault; Stephane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.